Cargando…
An Improved Detection of Circulating Tumor DNA in Extracellular Vesicles-Depleted Plasma
Circulating tumor DNA (ctDNA) in plasma has been used as a biomarker for cancer detection and outcome prediction. In this study, we collected the five precipitates (fractions 1–5) and leftover supernatant plasma component (fraction 6) by a sequential centrifugation in plasma samples from nine small...
Autores principales: | Sun, Li, Du, Meijun, Kohli, Manish, Huang, Chiang-Ching, Chen, Xiaoxiang, Xu, Mu, Shen, Hongbing, Wang, Shukui, Wang, Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226168/ https://www.ncbi.nlm.nih.gov/pubmed/34178690 http://dx.doi.org/10.3389/fonc.2021.691798 |
Ejemplares similares
-
Circulating Extracellular Vesicles in Gynecological Tumors: Realities and Challenges
por: Herrero, Carolina, et al.
Publicado: (2020) -
Bioinformatics Analysis for Circulating Cell-Free DNA in Cancer
por: Huang, Chiang-Ching, et al.
Publicado: (2019) -
Multiplex Digital PCR to Detect Amplifications of Specific Androgen Receptor Loci in Cell-Free DNA for Prognosis of Metastatic Castration-Resistant Prostate Cancer
por: Du, Meijun, et al.
Publicado: (2020) -
Plasma cell-free DNA–based predictors of response to abiraterone acetate/prednisone and prognostic factors in metastatic castration-resistant prostate cancer
por: Du, Meijun, et al.
Publicado: (2020) -
Detection of circulating KRAS mutant DNA in extracellular vesicles using droplet digital PCR in patients with colon cancer
por: Choi, Jeesoo, et al.
Publicado: (2022)